DALLAS, February 7, 2012 /PRNewswire/ --

ReportsnReports adds new market research report 'Branded Prescription Pharmaceutical Sales Outlook to 2016' to its store.  This research says in 2011, the Branded PharmaVitae Universe achieved sales of $558bn having experienced a compound annual growth rate (CAGR) of 9.3% between 2003 and 2010, and a net sales growth of $253bn. However, during 2011-16 sales are forecast to grow by a CAGR of only 1.0%, with no growth forecast in 2012, and branded prescription sales rising by just $29bn by 2016.

Request a Sample for the report on  Branded Prescription Pharmaceutical Sales

Report Highlights

 

By 2016 the small molecule market will contract by $5bn compared to 2011 sales as a direct consequence of the patent cliff and resultant generic erosion of branded sales. In preparation for this, the pharmaceutical industry has for some years been shifting its strategy to focus increasingly on high-growth markets such as biologics.

With US sales forecast to contract, pharmaceutical companies have turned to cost cutting and restructuring their US operations, while expanding in the high growth emerging markets. In fact, branded sales in the rest of world markets are forecast to represent 30.0% of sales in the Branded PharmaVitae Universe in 2016.

The pharmaceutical industry is shifting its R&D focus toward developing novel, high value, and often biologic therapies for the treatment of more niche indications. Reflecting this, infectious diseases and oncology are forecast to experience strong growth with additional sales of $10bn and $26bn by 2016, respectively.

Features and benefits

• Analyzes the forecast sales of the Branded PharmaVitae Universe according to molecule type
• Analyzes the forecast sales of the Branded PharmaVitae Universe according to therapy area
• Analyzes the forecast sales of the Branded PharmaVitae Universe according to geographical market
• Analyzes the forecast sales of the Branded PharmaVitae Universe according to formulation type

Your key questions answered

• Evaluate the evolving prescription pharmaceutical landscape and how this is set to impact Pharma out to 2016
• Quantify the size and growth of the pharmaceutical market
• Assess drivers and resistors of the prescription pharmaceutical market

Explore comprehensive Table of Contents, Inquire before Buying or Buy your copy of the report @ http://www.reportsnreports.com/reports/145676-branded-prescription-pharmaceutical-sales-outlook-to-2016.html.

Other recently published reports available with ReportsnReports:

• Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
• Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
• Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Find complete list of newly published market research reports @ http://www.reportsnreports.com/latest-market-research.aspx.

About Us:

ReportsnReports.com is an online market research library of 145,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit http://www.reportsnreports.com/ for more details.

Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog
Explore China specific Reports @ http:// marketreportschina.com/

SOURCE ReportsnReports

Back to top